Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | ARQT | TLX | ||
| Company | Nantkwest Inc CS | Arcutis Biotherapeutics Inc | Telix Pharmaceuticals Limited ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.34 | 27.49 | 10.43 | ||
| High | 33.15 | 28.87 | 10.56 | ||
| Low | 29.74 | 27.42 | 10.17 | ||
| Latest | 32.49 | 28.49 | 10.46 | ||
| Change | +4.21 | +0.75 | -0.37 | ||
| % Change | +14.89% | +2.70% | -3.42% | ||
| Volume | 1,109,000 | 1,265,300 | 132,100 | ||
| 20-Day Average Volume | 1,620,320 | 1,841,955 | 164,725 | ||
| Previous Close | 28.28 | 27.74 | 10.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 27.08 | 11.11 | ||
| 20-Day Raw Stochastic | 41.94% | 70.59% | 22.39% | ||
| 20-Day Relative Strength | 58.89 | 63.19 | 48.16 | ||
| Weighted Alpha | +342.67 | +75.50 | -17.86 | ||
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | ||
| Previous Opinion | 80% Buy | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | +2.70% since 07/10/26 | -6.10% since 07/10/26 | ||
| Low | 23.15 on 03/05/21 | 26.01 on 07/13/26 | 10.17 on 07/17/26 | ||
| High | 33.15 on 03/09/21 | 28.87 on 07/17/26 | 11.29 on 07/15/26 | ||
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | +8.66% since 06/17/26 | +5.23% since 06/17/26 | ||
| Low | 23.15 on 03/05/21 | 25.25 on 07/06/26 | 9.95 on 06/18/26 | ||
| High | 45.42 on 02/22/21 | 29.84 on 07/09/26 | 12.23 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | +16.14% since 04/17/26 | -2.61% since 04/17/26 | ||
| Low | 10.00 on 12/10/20 | 19.30 on 05/19/26 | 8.69 on 06/03/26 | ||
| High | 45.42 on 02/22/21 | 29.84 on 07/09/26 | 12.23 on 07/06/26 | ||
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | +10.21% since 01/16/26 | +34.79% since 01/16/26 | ||
| Low | 6.51 on 09/11/20 | 19.30 on 05/19/26 | 6.28 on 02/17/26 | ||
| High | 45.42 on 02/22/21 | 29.84 on 07/09/26 | 12.23 on 07/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 3,563,615 | 3,549,905 | ||
| Shares Outstanding, K | 109,345 | 125,083 | 339,379 | ||
| Annual Sales | 110,000 | 376,070,000 | 803,790,000 | ||
| Annual Net Income | -92,380,000 | -16,140,000 | -7,130,000 | ||
| Last Quarter Sales | 20,000 | 105,400,000 | N/A | ||
| Last Quarter Net Income | -32,140,000 | -11,300,000 | N/A | ||
| 60-Month Beta | 2.38 | 1.48 | -0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.09 on 05/06/26 | N/A | ||
| Earnings Date | 03/24/21 | 08/05/26 | 07/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||